LYTIR

Company · ASND

Ascendis Pharma A/S

Nasdaq's symbol directory lists ASND on Nasdaq as “Ascendis Pharma A/S - Ordinary Share”.

In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($493K); insiders sold on 2 occasions ($873K); 2 filings by holders of 5% or more.

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $493K in total; Insider sales: $873K in total.Aug: Insider purchases $493KSep: Insider sales $873KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $493KInsider sales below: $873K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Bodenhoff Mads, SVP & PAO sold on 1 day latest Sep 8, 2026 sold $811K
  2. Jean J. Bienaime bought on 1 day latest Aug 14, 2026 bought $493K
  3. HOLTUG LARS sold on 1 day latest Sep 2, 2026 sold $62K
Every trade (3)
  1. SELLBodenhoff Mads, SVP & PAO sold Sep 8, 2026 3,000 shares filing $811K
  2. SELLHOLTUG LARS sold Sep 2, 2026 236 shares filing $62K
  3. BUYJean J. Bienaime bought Aug 14, 2026 2,000 shares 2 legs combined filing $493K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. FMR LLC filed Nov 5, 2026 Schedule 13G/A passive 3,425,993 shares filing 5.2%
  2. Artisan Partners Asset Management Inc. filed Aug 13, 2026 Schedule 13G/A passive 2,634,024 shares filing 4.2%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.